Specialist Retinal Vein Occlusion Treatment
We offer advanced retinal vein occlusion treatment tailored to reduce swelling, stabilise vision, and prevent further damage.
Retinal vein occlusion (RVO) is a common vascular disorder of the retina that can lead to vision loss. It occurs when a retinal vein becomes blocked, leading to haemorrhages and fluid leakage in the retina.
Our comprehensive treatment of retinal vein occlusion includes:
- Anti-VEGF injections of Eylea (Aflibercept)
- Anti-VEGF injections of Lucentis (Ranibizumab)
- Intravitreal Dexamethasone implant (Ozurdex 700mcg)
Advanced Retinal Vein Occlusion Treatment Options
Effective retinal vein occlusion treatment aims to control swelling, improve vision, and minimise the risk of long-term complications. Early assessment and intervention provide the best outcomes.
Anti-VEGF injections, including Eylea and Lucentis, are widely used in the treatment of retinal vein occlusion. These medications block the vascular endothelial growth factor (VEGF), a protein that increases fluid leakage and promotes abnormal blood vessel growth. By reducing VEGF, these injections help stabilise retinal thickness and improve vision.
Intravitreal Dexamethasone implants (Ozurdex) provide a sustained release of steroids inside the eye to reduce inflammation and swelling. This long-lasting therapy offers significant relief for patients who require fewer injections or have persistent retinal oedema.
What our patients say
Book an appointment
FAQs on Retinal Vein Occlusion Treatment
Retinal vein occlusion occurs when a retinal vein becomes blocked, leading to fluid leakage, swelling, and potential vision loss. Early retinal vein occlusion treatment is essential to prevent permanent damage.
You may need the treatment of retinal vein occlusion if you experience blurred vision, distorted vision, dark patches, or sudden vision changes. A retinal examination will confirm the diagnosis and severity.
Anti-VEGF injections and Dexamethasone implants are the most effective retinal vein occlusion treatments, helping to reduce swelling, improve clarity, and prevent further deterioration.
Many patients see improvement within weeks of starting treatment for retinal vein occlusion, although ongoing monitoring and repeated therapy may be needed depending on the condition.
No. Numbing drops are used before injections or implant procedures, ensuring that treatments are comfortable with minimal discomfort.
While it cannot always be fully reversed, timely treatment of retinal vein occlusion can stabilise the condition, improve vision, and significantly reduce the risk of long-term vision loss.
Our Price List
| New consultation | £280 |
| Follow up | £220 |
| Full panretinal laser photocoagulation (PRP) x 3 sessions | £1200 |
| Fill-in panretinal laser photocoagulation (PRP) x 1 session | £450 |
| Avastin eye injection | £750 |
| Triamcinolone or Intracinol eye injections | £750 |
| Lucentis eye injection | £1,700 |
| Eylea eye injection | £1,800 |
| Vabysmo eye injection | £1,950 |
| Ozurdex eye injection | £2,800 |